Elanco Animal Health Incorporated

NYSE:ELAN

Drug Manufacturers - Specialty & Generic

Healthcare
$26.70 -3.47%

-$0.84 today

Market cap
$13.35B
Beta
1.70
P/E (TTM)
-48.1
EPS (TTM)
-$0.49
52W Low $13.16High $27.72

Volume 5.78M

Average 6.04M

ELAN Total Liabilities

Everything the company owes to creditors and other parties.

Elanco Animal Health IncorporatedNYSE: ELAN

Total Liabilities · Q3 FY2026 · quarter ended Sep 2026

Total liabilities broadly unchanged from a year ago

Total liabilities stood at $6.71B at the end of Q3 FY2026, down 1.3% from a year earlier and down 3.7% from the prior quarter. Over 3 fiscal years it compounded at -6.0% a year.

Context

  • Total liabilities amounted to 50.3% of total assets at the end of Q3 FY2026, up 0.1 pp from a year earlier.
  • Total liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total liabilities keeps falling in the next quarterly balance sheet after a -1.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$6.71B-3.7% QoQ
Last fiscal yearDec 2025
$6.81B+4.5% YoY
Year agoSep 2025
$6.8B-1.3% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.3%——
1 year+4.5%——
3-year CAGR-6.0%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
6.81B USD
Year-over-year change
+4.5%
4-year CAGR
-6.7%

Total Liabilities vs competitors

How ELAN compares with its peers on the latest reported figures

  • ELAN's Sep 2026 total liabilities of $6.71B is the 3rd highest of the 6 companies compared; the peer median is $1.22B.
  • Its year-over-year change of -1.3% is the 4th highest of 6, against a peer median of +3.0%.
  • Total liabilities amounts to 50.3% of total assets for ELAN, versus a peer median of 67.7%.
ELAN Competitors Peer median
Total Liabilities for ELAN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRKMerck & Co., Inc.Jun 2026$87.82B +28.3%+10.1%67.7%
ZTSZoetis Inc.Jun 2026$11.93B +25.5%+4.9%79.1%
ELANElanco Animal Health IncorporatedSep 2026$6.71B -1.3%-6.0%50.3%
NEOGNeogen CorporationAug 2026$1.22B -3.4%-4.1%36.8%
PAHCPhibro Animal Health CorporationMar 2026$1.08B +3.0%+17.1%75.0%
IDXXIDEXX Laboratories, Inc.Sep 2026$573.71M -68.6%-6.5%15.5%
Peer median (excluding ELAN) $1.22B+3.0%+4.9%67.7%

Competitors are the stored peer set for ELAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents638M345M352M468M545M
Short-term Investments00000
Net Receivables1.03B1B1.01B886M940M
Inventory1.37B1.54B1.74B1.57B1.74B
Other Current Assets0394M310M287M236M
Total Current Assets3.27B3.28B3.41B3.22B3.46B
Property, Plant & Equipment (Net)1.06B999M1.03B993M1.41B
Goodwill6.17B5.99B5.09B4.41B4.78B
Intangible Assets5.59B4.84B4.49B3.68B3.41B
Long-term Investments00000
Tax Assets00000
Other Non-current Assets390M378M341M311M304M
Total Non-current Assets13.2B12.21B10.96B9.4B9.9B
Total Assets16.48B15.49B14.36B12.61B13.36B
Account Payables416M390M270M296M368M
Short-term Debt294M388M38M44M74M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities937M924M933M975M1.16B
Total Current Liabilities1.65B1.7B1.24B1.32B1.6B
Long-term Debt6.03B5.45B5.74B4.28B3.94B
Deferred Tax Liabilities765M662M567M449M382M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities533M390M595M477M889M
Total Non-current Liabilities7.32B6.5B6.9B5.2B5.21B
Total Liabilities8.97B8.2B8.14B6.52B6.81B
Common Stock00000
Retained Earnings(979M)(1.06B)(2.29B)(1.95B)(2.18B)
Accumulated OCI(209M)(392M)(266M)(771M)(141M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity7.51B7.29B6.22B6.1B6.55B
Total Debt6.32B5.84B5.77B4.32B4.02B
Net Debt5.68B5.49B5.42B3.85B3.47B

Elanco Animal Health Incorporated

NYSE:ELAN

Intrinsic Alpha fair value

Locked

Current Price

$26.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.